
Tuning the gut: microbiome may boost cancer therapies
The gut microbiome is shaping cancer treatment outcomes, with research showing that preserving beneficial gut bacteria—rather than overusing broad-spectrum antibiotics—can improve responses to immunotherapy and transplants. Trials are testing probiotics like CBM588 and fecal microbiota transplants to repair dysbiosis and potentially reduce complications, while dietary strategies aim to support beneficial microbes. The field is promising but scientifically complex, and evidence is still accumulating.





